1,3-dipropyl-8-cyclopentylxanthine and rolipram

1,3-dipropyl-8-cyclopentylxanthine has been researched along with rolipram in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's4 (50.00)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Eigler, A; Endres, S; Greten, TF; Haslberger, C; Sinha, B; Sullivan, GW1
Bielenberg, GW; Eggert, B; Fischer, Y; Godes, M; Heiden, S; Hocher, B; Kalk, P; Relle, K; Sharkovska, Y; Ziegler, D1
Goshgarian, HG; Kajana, S1
Cascalheira, JF; Sebastião, AM; Serpa, A1
Muñoz, MD; Solís, JM1

Other Studies

8 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and rolipram

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
    Journal of medicinal chemistry, 2008, Jul-24, Volume: 51, Issue:14

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship

2008
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Endogenous adenosine curtails lipopolysaccharide-stimulated tumour necrosis factor synthesis.
    Scandinavian journal of immunology, 1997, Volume: 45, Issue:2

    Topics: Adenosine; Adenosine Deaminase; Caffeine; Dipyridamole; Humans; Inosine; Leukocytes, Mononuclear; Lipopolysaccharides; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Antagonists; Pyrrolidinones; Rolipram; Tumor Necrosis Factor-alpha; Xanthines

1997
The adenosine A1 receptor antagonist SLV320 reduces myocardial fibrosis in rats with 5/6 nephrectomy without affecting blood pressure.
    British journal of pharmacology, 2007, Volume: 151, Issue:7

    Topics: Adenosine; Adenosine A1 Receptor Antagonists; Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Pressure; Cell Line; Collagen Type I; Collagen Type III; Creatine Kinase; Cyclohexanes; Endomyocardial Fibrosis; Fibronectins; Glomerular Filtration Rate; Heterocyclic Compounds, 2-Ring; Humans; Male; Molecular Structure; Myocardium; Nephrectomy; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A1; Rolipram; U937 Cells; Xanthines

2007
Administration of phosphodiesterase inhibitors and an adenosine A1 receptor antagonist induces phrenic nerve recovery in high cervical spinal cord injured rats.
    Experimental neurology, 2008, Volume: 210, Issue:2

    Topics: Action Potentials; Animals; Cervical Vertebrae; Diaphragm; Disease Models, Animal; Electromyography; Male; Pentoxifylline; Phosphodiesterase Inhibitors; Phrenic Nerve; Rats; Rats, Sprague-Dawley; Recovery of Function; Respiration; Rolipram; Spinal Cord Injuries; Time Factors; Xanthines

2008
Modulation of cGMP accumulation by adenosine A1 receptors at the hippocampus: influence of cGMP levels and gender.
    European journal of pharmacology, 2014, Dec-05, Volume: 744

    Topics: Adenosine; Adenosine Deaminase; Animals; Colforsin; Cyclic AMP; Cyclic GMP; Female; Hippocampus; Imidazoles; Male; Nitroprusside; Rats; Rats, Wistar; Receptor, Adenosine A1; Rolipram; Triazines; Xanthines

2014
Characterisation of the mechanisms underlying the special sensitivity of the CA2 hippocampal area to adenosine receptor antagonists.
    Neuropharmacology, 2019, Volume: 144

    Topics: Adenylyl Cyclases; Animals; CA1 Region, Hippocampal; CA2 Region, Hippocampal; Caffeine; Colforsin; Excitatory Postsynaptic Potentials; Male; Phosphodiesterase Inhibitors; Purinergic Agonists; Purinergic P1 Receptor Antagonists; Rats, Sprague-Dawley; Receptor, Adenosine A1; Rolipram; Synapses; Tissue Culture Techniques; Xanthines

2019